glp 1 gip dual agonist Free Comparison Chart: GLP-1 and GIP/GLP-1 Receptor Agonists for Type 2 Diabetes π Link in bio #FOAMed #Type2Diabetes #GLP1 Schematic illustration of monoagonists, dual
Description
Bias in meta-analysis detected by a simple, graphical test
Placebo-controlled, randomized trial of the addition of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes (AWARD-9) Diabetes, Obesity and Metabolism
In the obesity trial, maximal WL was achieved with retatrutide 12 mg after 48 weeks: -24.2% vs
Total body weight is a composite of fat mass, lean muscle mass, bone density, water, and organ tissue
Mercier, O
Novo Nordisk fails to keep up with Eli Lilly in first half of 2025 Novo Nordisk stock is down 37.70% YTD
